Society for Clinical Research Sites Welcomes ICON as New Global Impact Partner

Ellicott City, M.D., November 5, 2015 – The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests of clinical research sites, today announced a two-year relationship with ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. ICON will participate as a Global Impact Partner (GIP) and align with 31 other sponsors, CROs, and service providers dedicated to promoting high-level communication and meaningful collaboration between industry stakeholders and clinical research sites globally.

“ICON’s relationship with SCRS reinforces their commitment to strengthening site partnerships and furthering alliance with industry stakeholders,” commented Christine Pierre, SCRS President. “Collaboration with ICON is a significant strategic development for SCRS, and we are extremely pleased to welcome them as our newest GIP.”

“Building a close connection with research sites and patients is an integral part of helping our clients to take time and cost from their development programmes,” commented Lollo Eriksson, Executive Vice President, Site and Patient Recruitment, ICON. “We are pleased to collaborate with the SCRS as a Global Impact Partner and we look forward to working with them to promote global clinical research and building patient awareness. Our partnership with SCRS, together with our work with IBM Watson Clinical Trial Matching are examples of some of the initiatives we are working on to enhance patient recruitment and study start-up.”

As a Global Impact Partner (GIP), ICON will participate on the SCRS Global Impact Board at an executive level, and work closely with SCRS’ Leadership Council to determine strategic initiatives for SCRS.

####       

About SCRS
SCRS is a global trade organization founded in 2012 which represents over 2,600 research sites in 42 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites, as well as companies that sponsor or support the work conducted at clinical research sites, will benefit from membership and partnership. Visit MySCRS.org.

ICON plc is a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON currently, operates from 77 locations in 38 countries and has approximately 11,700 employees. More information is at www.iconplc.com